Your browser doesn't support javascript.
loading
Cell-Free DNA: Hope and Potential Application in Cancer.
Yan, Yan-Yan; Guo, Qiao-Ru; Wang, Feng-Hua; Adhikari, Rameshwar; Zhu, Zhuang-Yan; Zhang, Hai-Yan; Zhou, Wen-Min; Yu, Hua; Li, Jing-Quan; Zhang, Jian-Ye.
Afiliación
  • Yan YY; School of Medicine, Shanxi Datong University, Datong, China.
  • Guo QR; Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Wang FH; Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Adhikari R; The First Affiliated Hospital, Hainan Medical University, Haikou, China.
  • Zhu ZY; Guangzhou Institute of Pediatrics/Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Zhang HY; Research Centre for Applied Science and Technology, Tribhuvan University, Kirtipur, Nepal.
  • Zhou WM; School of Medicine, Shanxi Datong University, Datong, China.
  • Yu H; School of Medicine, Shanxi Datong University, Datong, China.
  • Li JQ; Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zhang JY; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Avenida da Universidade, Taipa, China.
Front Cell Dev Biol ; 9: 639233, 2021.
Article en En | MEDLINE | ID: mdl-33693004
Cell-free DNA (cfDNA) is easily accessible in peripheral blood and can be used as biomarkers for cancer diagnostics, prognostics, and therapeutics. The applications of cfDNA in various areas of cancer management are attracting attention. In this review article, we discuss the potential relevance of using cfDNA analysis in clinical oncology, particularly in cancer screening, early diagnosis, therapeutic evaluation, monitoring disease progression; and determining disease prognosis.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: China